Home/Filings/4/0001385508-22-000104
4//SEC Filing

Ellison Mark Jason Heath 4

Accession 0001385508-22-000104

CIK 0001385508other

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 4:07 PM ET

Size

5.1 KB

Accession

0001385508-22-000104

Insider Transaction Report

Form 4
Period: 2022-06-27
Transactions
  • Award

    Common Stock

    2022-06-27+2,00021,636 total
Footnotes (1)
  • [F1]Represents the acquisition of shares upon the determination on June 27, 2020 by the Compensation and Human Capital Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to a portion of the performance stock units granted to the Reporting Person on January 4, 2022.

Issuer

OPIANT PHARMACEUTICALS, INC.

CIK 0001385508

Entity typeother

Related Parties

1
  • filerCIK 0001781982

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:07 PM ET
Size
5.1 KB